Vault-13

SR One Capital Management, LP

Redwood City, CA · CIK 1910264 · 13F filing filed 2023-08-10

SEC-registered investment adviser since 2020 · limited partnership

$231.9m reported value -13.6% vs Q1 2023
6positions
100.0%in top 10
0 new 0 added 1 reduced 0 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARCELLX INC COMMON STOCK ACLX ACLX 3,946,630 $124.8m53.81% 53.81% ReducedShares held: Q3 2022 5.5m, Q4 2022 5.5m, Q1 2023 5.5m, Q2 2023 3.9m -1.6m -1,553,377 -28.2%
2 DESIGN THERAPEUTICS INC COM DSGN DSGN 6,526,476 $41.1m17.73% 17.73% UnchangedShares held: Q3 2022 5.6m, Q4 2022 6.5m, Q1 2023 6.5m, Q2 2023 6.5m
3 MINERALYS THERAPEUTICS INC COM MLYS MLYS 1,794,600 $30.6m13.19% 13.19% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.8m, Q2 2023 1.8m
4 ARS PHARMACEUTICALS INC COM SPRY SPRY 4,012,903 $26.9m11.59% 11.59% UnchangedShares held: Q3 2022 0, Q4 2022 3.0m, Q1 2023 4.0m, Q2 2023 4.0m
5 EFFECTOR THERAPEUTICS INC COM COM 6,822,114 $5.6m2.41% 2.41% UnchangedShares held: Q3 2022 6.8m, Q4 2022 6.8m, Q1 2023 6.8m, Q2 2023 6.8m
6 NKARTA INC COM NKTX NKTX 1,333,333 $2.9m1.26% 1.26% UnchangedShares held: Q3 2022 1.3m, Q4 2022 1.3m, Q1 2023 1.3m, Q2 2023 1.3m